Handelsbanken Fonder Ab Turning Point Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 03, 2022	BUY	$24.32 - $75.3 $179,968 - $557,220	7,400 New	7,400 $557,000
Q1 2022 May 11, 2022	SELL	$24.73 - $51.25 $183,002 - $379,250	-7,400 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$35.48 - $67.33 $6.58 Million - $12.5 Million	-185,400 Reduced 96.16%	7,400 $353,000
Q3 2021 Nov 10, 2021	BUY	$61.0 - $81.99 $1.28 Million - $1.72 Million	21,000 Added 12.22%	192,800 $12.8 Million
Q2 2021 Aug 03, 2021	BUY	$62.93 - $90.59 $1.9 Million - $2.74 Million	30,200 Added 21.33%	171,800 $13.4 Million
Q1 2021 Apr 29, 2021	BUY	$88.19 - $140.01 $105,828 - $168,012	1,200 Added 0.85%	141,600 $13.4 Million
Q4 2020 Feb 11, 2021	SELL	$87.69 - $130.94 $3.07 Million - $4.58 Million	-35,000 Reduced 19.95%	140,400 $17.1 Million
Q3 2020 Nov 13, 2020	BUY	$56.99 - $89.33 $4.56 Million - $7.15 Million	80,000 Added 83.86%	175,400 $15.3 Million
Q2 2020 Aug 13, 2020	BUY	$39.94 - $70.39 $3.81 Million - $6.72 Million	95,400 New	95,400 $6.16 Million

About Turning Point Therapeutics, Inc.

Ticker TPTX
Exchange NASDAQ
Shares Outstandng 50,074,300

More about TPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.